LRFN2
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
leucine rich repeat and fibronectin type III domain containing 2 | MIM:612808 | Ensembl:ENSG00000156564 | HGNC:HGNC:21226 | PA134913285 | 6p21.2-p21.1 |
Gene Categories:
CELL SURFACEGO terms in LRFN2
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | TAS | GO:0005886 | plasma membrane |
CC | IEA | GO:0009986 | cell surface |
CC | IEA | GO:0016021 | integral component of membrane |
CC | IEA | GO:0030054 | cell junction |
CC | IEA | GO:0045211 | postsynaptic membrane |
Gene expression in normal tissue: LRFN2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in LRFN2
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-112316 | Neuronal System |
reactome | R-HSA-6794362 | Protein-protein interactions at synapses |
reactome | R-HSA-8849932 | Synaptic adhesion-like molecules |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in LRFN2